Delivery Order SPE2DB22D3301-SPE2DB25FZ0KY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,925.36 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials. This contract type represents a firm fixed price delivery order with an ultimate completion date of September 18, 2025, and was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials, with a ceiling value of $1,422.92. This order was competitively awarded without set-aside designation and carries a firm fixed price contract type with an ultimate completion date of September 12, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Remifentanil 2 mg vials with a ceiling value of $1,675.46. The contract utilizes a firm fixed price structure and represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This delivery order was competitively awarded with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Remifentanil 1 mg vials, valued at $7,489.63 under a firm fixed-price contract. The award was made on September 15, 2025, with an ultimate completion date of September 16, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,193.89 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Remifentanil is a potent synthetic opioid analgesic commonly used in medical and surgical...
- The Defense Logistics Agency awarded a delivery order valued at $3,426.20 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials, with an ultimate completion date of September 4, 2025. This non-set-aside contract employs firm fixed pricing and represents a competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,315.50 to AmerisourceBergen Drug Corp for the supply of Remifentanil 1 mg vials, with an ultimate completion date of June 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and designates Conshohocken, Pennsylvania as the place of performance. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials under a firm fixed-price contract. The award, issued on August 11, 2025, carries a ceiling value of $7,572.90 with an ultimate completion date of August 12, 2025. This delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Remifentanil is a potent synthetic opioid...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,941.00 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials. This firm fixed-price contract, issued on June 6, 2025, with an ultimate completion date of June 9, 2025, represents a competitive award with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Remifentanil is a potent synthetic...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $13,585.09 delivery order on September 19, 2025, for the supply of Remifentanil 2 mg vials. This is a competitively awarded, firm fixed-price contract with no set-aside designation and an ultimate completion date of September 22, 2025. The contract is funded by the Medical Supply Chain, a defense-focused federal agency supporting military and veteran healthcare systems. This...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0KYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,983.47 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials, a potent opioid analgesic commonly used in clinical and surgical settings. This firm fixed-price delivery order, awarded on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively awarded under open competition standards. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant $999,999,999.00 prime IDC with DLA Troop Support Medical (SPE2DX) extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a diverse range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The delivery order for Remifentanil 2 mg vials exemplifies AmerisourceBergen's role as a critical federal medical vendor, serving defense health systems and supporting the military's clinical and surgical pharmacy needs through DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 9/3/25 |